The Galleri test is a prescription-only blood test that screens for a signal shared by over 50 types of cancer. It uses advanced DNA methylation analysis to detect abnormal patterns in cell-free DNA (cfDNA) shed by cancer cells. It complements, but does not replace, standard cancer screening tests. The test is not currently FDA approved.
Who Should Buy This Kit:
This test is ideal for adults aged 50 or older or individuals with elevated risk for cancer, as verified by a licensed healthcare provider. It is especially recommended for individuals:
- Seeking early cancer detection
- With a family history of cancer
- Interested in proactive screening beyond standard methods
Medications and Protocol:
- Screens for cancer DNA signals via blood sample
- Single test, results returned within 2–3 weeks
Protocol Overview:
- Week 1: Patient receives lab order and completes blood draw
- Week 2: Galleri® processes the sample and returns results to provider
- Week 3–4: Provider follows up with patient based on results
Lab Orders (if applicable):
Baseline: Blood sample drawn to initiate screening
Sale Process:
Patient completes consultation and payment for prescription. Galleri sends blood draw kit and processes results. Patient receives direct follow-up.
Why This Pack is Important:
Early cancer detection can significantly improve treatment outcomes and survival rates. Galleri allows for proactive monitoring of over 50 cancer types, many of which have no routine screening.
Key Features:
- Screens for 50+ cancers with one blood test
- Cutting-edge DNA methylation technology
- Complements standard cancer screening
Considerations:
- Not FDA approved
- False positives and negatives possible
- Follow-up diagnostics required for positive results